Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Biomaterials (Orthopedic: Synthetic Bone, Cartilage & Skin Substitutes)

Carmell Therapeutics

Parents

Architects: Biomaterials (Orthopedic: Synthetic Bone, Cartilage & Skin Substitutes)
Industry: Pittsburgh, Pennsylvania
Venture Capital: Series A

After it’s placed in the body, the scaffold deteriorates over a period of four to six weeks while treating the injury.
Carmell also is developing a second product, a bone putty.
Carmell Therapeutics raises $3M to develop blood plasma medical devices (2011)
Carmell’s products are biologically active plastics made of blood plasma to treat sports injuries to bone and connective tissue.
Founded 2007
Pittsburgh, Pennsylvania
The A round was led by New Hampshire-based Harbor Light Capital Partners and included participation from Newlin Investment Company, Pittsburgh Life Sciences Greenhouse, Innovation Works, Ariel Savannah Angels and Blue Tree Allied Angels
The company refers to its plastics as “the ideal biomaterials” because they use the body’s own growth and regenerative factors to promote healing.
The company’s first product is a surgical scaffold that’s placed arthroscopically between the bone and tendon to treat rotator cuff and tendon injuries.